322 Preclinical assessment of allogeneic Anti-CD5 γδ CAR-T therapy for T-Cell malignancies

Affiliations

Young Ho Lee: 4Rheumatology, Korea University College of Medicine, Republic of Korea
Seung Rok Yu: Curocell Inc., Daejeon, Daejeon, Republic of Korea
Hyeong Ji Lee: Curocell Inc., Daejeon, Daejeon, Republic of Korea
Jeong Hoon Jeong: Curocell Inc., Daejeon, Daejeon, Republic of Korea
Hyeon Jeong Cho: Curocell Inc., Daejeon, Daejeon, Republic of Korea
Hyo Bhin Lee: Curocell Inc., Daejeon, Daejeon, Republic of Korea
Hyung Cheol Kim: Curocell Inc., Daejeon, Daejeon, Republic of Korea

Abstract

No abstracts available.

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com